Bio-Pharmaceuticals Market in India 2017

Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.

Bio-pharmaceuticals Industry in India (2018-2023)

Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.

Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. ‘Pharma Vision 2020’ has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.

Key growth drivers of the market:

India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.
Key deterrents to the growth of the market:
It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
 

Companies covered:
Biocon Ltd.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Wockhardt Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.
 

Chapter 1: Executive summary


Chapter 2: Socio-economic indicators



Chapter 3: Introduction

1.1. Bio-pharmaceuticals market definition and structure
1.2. Bio-pharmaceuticals value chain


Chapter 4: Global pharmaceuticals market

4.1. Market overview
4.2. Market segmentation
4.2.1. Pharmaceuticals market value - country-wise split (2017)

USA
Japan
China
Germany
France
Others
4.2.2. Pharmaceutical spending - region-wise split (2020e)

USA
EU-5
Others
4.2.3. Pharmaceuticals market players - ranking (2017)
4.3. Bio-pharmaceuticals sales growth (2007-2017)

Chapter 5: India bio-pharmaceuticals market

5.1. Market overview
5.2. Market size and growth forecast - value-wise (FY 2016-FY 2023e)
5.3. Market segmentation
5.3.1. Revenue-wise market breakup (FY 2016)
5.3.2. Top five pharmaceutical company market share (2018)

Cipla
Aurobindo Pharma
Lupin
Others
5.4. Recent investments in the market
5.5. Government initiatives
5.6. Biotechnology and pharmaceutical research and development (R&D) hubs in India - overview
5.7. Porter’s five forces analysis

Chapter 6: Trade analysis

6.1. Export of bio-pharmaceuticals

Value-wise
Volume-wise
Country-wise
6.2. Import of bio-pharmaceuticals

Value-wise
Volume-wise
Country-wise

Chapter 7: Key growth drivers of the market



Chapter 8: Key deterrents to the growth of the market



Chapter 9: Competitive landscape

9.1. Biocon Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.2. Cadila Healthcare Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.3. Dr Reddy’s Laboratories Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.4. Panacea Biotec Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.5. Wockhardt Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.6. GSK Pharmaceuticals Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.7. Bharat Biotech International Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.8. Bharat Serums and Vaccines Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.9. Indian Immunologicals Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
9.10. Serum Institute of India Pvt. Ltd.

Corporate information
Business description
Products and services
Key people
Financial snapshot (total income, net profit/loss)
Key ratios
Business segments, geographic segments
Production capacities
Chapter 10: Recent developments



Appendix



Companies Profiled

Biocon Ltd.
Cadila Healthcare Ltd.
Dr Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Wockhardt Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.

 


Bio-Pharmaceuticals Market in India 2017

The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023

USD 950 View Report

Global Bio-pharmaceuticals Market Size and Forecast to 2021

Bio-pharmaceuticals Report by Material, Application, and Geography Global Forecast to 2021 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main

USD 1990 View Report

Global Online Food Delivery and Takeaway Market (2019 Edition) – Analysis By Order Type (Delivery, Takeaway & Dine-in), By Region, By Country: Market Insights, Company Analysis, Opportunity Assessment and Forecast (2014-2024)

Executive A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Online Food

USD 2400 View Report

Tourism Source Market Insight: Gulf Cooperation Council

Tourism Source Market Insight: Gulf Cooperation CouncilTourism Source Market Insight: Gulf Cooperation Council report provides a thorough insight into the GCCs domestic and outbound tourism market. The report looks at

USD 1495 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available